IPO

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO

Livemint Markets

Jul 24, 2026 · 10:21 PM 1 min reading time

Scribe Therapeutics, a developer of gene therapies for heart diseases, rose 67% after raising $128.7 million in its IPO.

Read full original report at Livemint Markets Visit Source

Twitter LinkedIn WhatsApp Telegram

The bond rout is bruising would-be home buyers—and challenging the Fed

Investors’ worries about government debt, plus their increased expectations that the Fed will hike rates this year, are also affecting bond prices and raising yields.

Read Story

IPO

Livemint Markets • Just now • 1 min

Expert view: Semiconductors, spacetech could unlock $500 bn-$1 tn market opportunity, says Piper Serica's Director

India appears to be on the brink of a technology revolution, with semiconductors, spacetech, and deeptech poised to reshape its economic landscape. Ajay Modi, Director at Piper Serica, believes these industries have the potential to create a market opportunity of $500 billion to $1 trillion. 

Read Story

IPO

Livemint Markets • 6h ago • 1 min

Gold Edges Up as Traders Weigh Mideast Conflict, Fed Rate Path

Gold edged higher, holding firmly above the key resistance point of $4,000 an ounce even as the widening conflict in the Middle East fuels expectations for tighter monetary policy.

Read Story

IPO

Livemint Markets • 11h ago • 1 min

Metals Fluctuate as Middle East Escalation Keeps Bulls in Check

Base metals fluctuated at the end of the week as the threat of an escalating conflict in the Middle East — and more turbulence for the global economy — kept a lid on optimism.

Read Story

IC Electricals Issue: ₹99.00

+₹44.00 +44.4%

Kusumgar Issue: ₹419.00

+₹139.00 +33.2%

Adon Agro Commodities Issue: ₹70.00

+₹0.00 +0.0%

Aastha Spintex Issue: ₹136.00

+₹6.25 +4.6%

Twinkle Papers Issue: ₹69.00

+₹9.00 +13.0%

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO

Share Article

Related Stories

The bond rout is bruising would-be home buyers—and challenging the Fed

Expert view: Semiconductors, spacetech could unlock $500 bn-$1 tn market opportunity, says Piper Serica's Director

Gold Edges Up as Traders Weigh Mideast Conflict, Fed Rate Path

Metals Fluctuate as Middle East Escalation Keeps Bulls in Check